News | June 22, 2012

MD Anderson Orlando First in Florida to Offer Radiation Treatment with TomoHD System

Left, Robert Staton, Ph.D., medical physicist, and Michael Brown, RTT

From left, Robert Staton, Ph.D., medical physicist, and Michael Brown, RTT, chief radiation therapist with the first TomoHD system now in operation at MD Anderson Orlando.

June 22, 2012 — MD Anderson Cancer Center Orlando announced it has installed the first Accuray TomoHD system in Florida.

Unlike traditional radiation therapy devices, the TomoHD system combines fully integrated computed tomography (CT) imaging and intensity-modulated radiation therapy (IMRT) on a CT scanner platform. Each daily treatment includes a 3-D image of the patient’s anatomy to ensure highly accurate radiation delivery. This provides clinicians unprecedented confidence that tumors will receive their intended dosage from one day to the next.

A major difference with the TomoHD system is the way that radiation is delivered to the treatment area. The radiation beam is divided into thousands of tiny “beamlets” all aiming at the tumor during multiple 360-degree rotations around the patient. The treatment dose conforms to the tumor and avoids critical organs, which can mean improved outcomes, fewer side effects and a higher quality of life for the patient.

“We have continually been a leader in delivering the most accurate and individualized TomoTherapy treatments and we are thrilled to have this state-of-the-art technology available to our patients,” said Mark Roh, M.D., president of MD Anderson Orlando. “Our new TomoHD system will not only provide the highest quality of radiation treatment to our patients battling complex cancers, it will also be a tool for our oncologists to educate clinicians on best practice TomoTherapy treatment techniques for patients worldwide.”

“We congratulate MD Anderson Cancer Center Orlando on the installation of their TomoHD system,” said Omar Dawood, M.D., M.P.H., senior vice president of global medical affairs for Accuray. “The TomoHD system will provide them with the ability to target tumors with extreme accuracy and allow them to create highly individualized treatments for each patient. Their choice to offer this technology to their patients affirms the importance of the TomoHD system in supporting their place as a leader in the radiation oncology community with a continued commitment to patient care.”

For more information:,

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init